Oaktree Acquisition Corp. III Life Sciences
OACCU- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002029769
No open-market purchases or sales by Oaktree Acquisition Corp. III Life Sciences insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $9.24M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Oaktree Acquisition Corp. III Life Sciences as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +19 vs. Q3 2024
- Shares held
- 8.61M
- +8.61M vs. Q3 2024
- Total value
- $87.3M
- +$87.3M vs. Q3 2024
- New holders
- 19
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OACCU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $9.24M |
| Q1 2026 | 6 | $9.07M |
| Q4 2025 | 5 | $9.02M |
| Q3 2025 | 5 | $8.99M |
| Q2 2025 | 6 | $9.54M |
| Q1 2025 | 11 | $29.7M |
| Q4 2024 | 19 | $87.3M |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Oaktree Acquisition Corp. III Life Sciences; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Healthcare of Ontario Pension Plan Trust Fund | 1,700,000 | $17.3M | 0.04% | +1,700,000 | New |
| Millennium Management LLC | 952,422 | $9.65M | 0.01% | +952,422 | New |
| Driehaus Capital Management LLC | 900,000 | $9.11M | 0.08% | +900,000 | New |
| Schonfeld Strategic Advisors LLC | 840,828 | $8.52M | 0.05% | +840,828 | New |
| Linden Advisors LP | 600,000 | $6.09M | 0.05% | +600,000 | New |
| Moore Capital Management, LP | 525,000 | $5.33M | 0.10% | +525,000 | New |
| ADAR1 Capital Management, LLC | 500,000 | $5.07M | 1.04% | +500,000 | New |
| LMR Partners LLP | 475,000 | $4.81M | 0.08% | +475,000 | New |
| Hudson Bay Capital Management LP | 450,000 | $4.57M | 0.03% | +450,000 | New |
| Periscope Capital Inc. | 450,000 | $4.56M | 3.23% | +450,000 | New |
| Ghisallo Capital Management LLC | 450,000 | $4.56M | 0.27% | +450,000 | New |
| Affinity Asset Advisors, LLC | 250,000 | $2.54M | 0.40% | +250,000 | New |
| Whitebox Advisors LLC | 250,000 | $2.53M | 0.09% | +250,000 | New |
| Picton Mahoney Asset Management | 75,000 | $760.0K | 0.03% | +75,000 | New |
| Kepos Capital LP | 70,000 | $709.0K | 0.61% | +70,000 | New |
| Citigroup Inc | 50,900 | $515.6K | 0.00% | +50,900 | New |
| Athos Capital Ltd | 50,000 | $507.0K | 0.24% | +50,000 | New |
| Rangeley Capital, LLC | 10,000 | $101.3K | 0.10% | +10,000 | New |
| UBS Group AG | 9,483 | $95.9K | 0.00% | +9,483 | New |